Ishiguro, H., Ushiki, T., Honda, A., Yoshimatsu, Y., Ohashi, R., Okuda, S., Kawasaki, A., Cho, K., Tamura, S., Suwabe, T., Katagiri, T., Ling, Y., Iijima, A., Mikami, T., Kitgawa, H,, Uemura, A., Sango, K., Masuko, M., Igarashi, M., Sone, H. Reduced chondroitin sulfate content prevents diabetic neuropathy through transforming growth factor-β signaling suppression. iScience 27(4):109528.